☆ 4.6 Review

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

CANCERS (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT)

Thomas Helmberger et al.

Summary: The CIRT study analyzed 1027 patients and found that a majority of treatment intentions were palliative. Various malignant tumors had different median overall survival rates, and significant prognostic factors for survival included the presence of ascites, cirrhosis, extra-hepatic disease, patient performance status (ECOG), number of chemotherapy lines prior to TARE, and tumor burden.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial

Tae Hyun Kim et al.

Summary: The study compared proton beam radiotherapy (PBT) and radiofrequency ablation (RFA) outcomes in patients with recurrent/residual HCC, demonstrating non-inferiority of PBT in terms of 2-year local progression-free survival (LPFS). The most common adverse events with PBT were radiation pneumonitis and decreased leukocyte counts, while RFA resulted in increased alanine aminotransferase levels and abdominal pain. PBT was found to be a tolerable and safe treatment option for patients with small recurrent hepatocellular carcinoma.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Oncology

Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study

Jihye Lim et al.

Summary: In patients with portal vein tumor thrombosis (PVTT), there is an increased risk of high-risk esophageal varices and variceal bleeding. Endoscopic prevention may be considered for high-risk variceal carriers with PVTT, especially those undergoing sorafenib treatment for HCC.

BMC CANCER (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

Etienne Garin et al.

Summary: This study compared the efficacy of personalized versus standard dosimetry in selective internal radiation therapy for advanced hepatocellular carcinoma, showing that personalized dosimetry significantly improved the objective response rate. The results suggest that personalized dosimetry may enhance outcomes in clinical practice and should be considered for future trials.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Locoregional therapies, including local ablation and transarterial chemoembolization, play a crucial role in the management of hepatocellular carcinoma. Recent studies have shown potential benefits of combining these local therapies with systemic treatments, such as molecular therapies, to enhance therapeutic effects.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Standardization of conventional chemoembolization for hepatocellular carcinoma

Matteo Renzulli et al.

Summary: The study evaluated the chemical and physical characteristics of emulsions for cTACE and assessed intra-and inter-operator variabilities in the preparation processes. The results showed that droplet diameter changed with the number of pumping exchanges and over time, but returned to initial sizes after remixing. The study suggests that any interventional radiologist can prepare these emulsions, regardless of experience, and these data may provide guidelines for standardizing cTACE procedures.

ANNALS OF HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study

Riad Salem et al.

Summary: The LEGACY study evaluated the efficacy of yttrium-90 glass microspheres in treating solitary, unresectable HCC <= 8 cm, showing promising response rates and durable responses in a multicenter setting.

HEPATOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study

Aline Maehringer-Kunz et al.

Summary: Portal vein tumor thrombosis (PVTT) is a common complication of hepatocellular carcinoma (HCC) classified as advanced stage disease. This study analyzed treatment-naive HCC patients with PVTT to determine the impact of different treatments based on the extent of PVTT. Resection may be a more effective treatment option for patients with segmental PVTT (Vp1) compared to systemic therapy.

PLOS ONE (2021)

添加到收藏夹

Review Oncology

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Masatoshi Kudo et al.

Summary: The Clinical Practice Manual for Hepatocellular Carcinoma is based on evidence and expert consensus, focusing on pathology, diagnosis, and treatment. Different from the JSH Clinical Practice Guidelines, this manual emphasizes practicality and is written by a panel of experts from the JSH.

LIVER CANCER (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Transarterial Radioembolization for Hepatocellular Carcinoma with Major Vascular updates Invasion: A Nationwide Propensity Score-Matched Analysis with Target Trial Emulation

Sandi A. Kwee et al.

Summary: The study examined NCDB data and found that TARE offers significant survival benefits for patients with HCC-MVI, especially in specific populations. The research also highlights the increasing use of TARE, suggesting it may become an important treatment option for patients with HCC-MVI.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2021)

添加到收藏夹

Article Oncology

Efficacy and safety of liver-directed concurrent chemoradiotherapy and sequential sorafenib for advanced hepatocellular carcinoma; a prospective phase 2 trial

Beom Kyung Kim et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

添加到收藏夹

Article Oncology

Transarterial Radioembolization for Hepatocellular Carcinoma and Hepatic Metastases: Clinical Aspects and Dosimetry Models

Justin K. Mikell et al.

SEMINARS IN RADIATION ONCOLOGY (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis

Shuangxi Li et al.

BRITISH JOURNAL OF RADIOLOGY (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

NEMESIS: Noninferiority, Individual-Patient Metaanalysis of Selective Internal Radiation Therapy with 90Y Resin Microspheres Versus Sorafenib in Advanced Hepatocellular Carcinoma

Marino Venerito et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Oncology

Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Kazuomi Ueshima et al.

LIVER CANCER (2020)

添加到收藏夹

Article Oncology

Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study

Xiaoyan Ding et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

Sojung Han et al.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2020)

添加到收藏夹

Article Oncology

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion A Randomized Clinical Trial

MinKe He et al.

JAMA ONCOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

Jens Ricke et al.

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers

Lucia Cerrito et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

添加到收藏夹

Article Oncology

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis

Jen-Fu Yang et al.

RADIATION ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis

Jong Hwan Choi et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)

添加到收藏夹

Article Oncology

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

Pierce K. H. Chow et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion A Randomized Clinical Trial

Sang Min Yoon et al.

JAMA ONCOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

Yi-Sheng Liu et al.

BMC GASTROENTEROLOGY (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres

C. Bouvry et al.

BIOMED RESEARCH INTERNATIONAL (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges

Aikaterini Mantaka et al.

ANNALS OF GASTROENTEROLOGY (2018)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization

Boris Gorodetski et al.

EUROPEAN RADIOLOGY (2017)

添加到收藏夹

Article Oncology

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valerie Vilgrain et al.

LANCET ONCOLOGY (2017)

添加到收藏夹

Review Oncology

Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

XiuPing Zhang et al.

ONCOTARGET (2017)

添加到收藏夹

Article Oncology

Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial

Antonio Giorgio et al.

ANTICANCER RESEARCH (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

Riad Salem et al.

GASTROENTEROLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study

Jiang Long et al.

HEPATOLOGY INTERNATIONAL (2016)

添加到收藏夹

Article Oncology

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Theodore S. Hong et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion

Takashi Kokudo et al.

JOURNAL OF HEPATOLOGY (2016)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Personalized Dosimetry with Intensification Using Y-90-Loaded Glass Microsphere Radioembolization Induces Prolonged Overall Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis

Etienne Garin et al.

JOURNAL OF NUCLEAR MEDICINE (2015)

添加到收藏夹

Article Oncology

Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification

Jiang-feng Xu et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)

添加到收藏夹

Review Oncology

Promise and Pitfalls of Heavy-Particle Therapy

Timur Mitin et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib-A Retrospective Controlled Study

Kangshun Zhu et al.

RADIOLOGY (2014)

添加到收藏夹

Review Oncology

Side effects of yttrium-90 radioembolization

Ahsun Riaz et al.

FRONTIERS IN ONCOLOGY (2014)

添加到收藏夹

Article Oncology

Resection of Hepatocellular Carcinoma with Macroscopic Vascular Invasion

Sasan Roayaie et al.

ANNALS OF SURGICAL ONCOLOGY (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis

Tong-Chun Xue et al.

BMC GASTROENTEROLOGY (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept

E. Garin et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Prognostic factors and prevention of radioembolization-induced liver disease

Belen Gil-Alzugaray et al.

HEPATOLOGY (2013)

添加到收藏夹

Article Oncology

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

Alexis Bujold et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cryotherapy is Associated with Improved Clinical Outcomes of Sorafenib Therapy for Advanced Hepatocellular Carcinoma

Yongping Yang et al.

CELL BIOCHEMISTRY AND BIOPHYSICS (2012)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib

Matthias Pinter et al.

RADIOLOGY (2012)

添加到收藏夹

Article Oncology

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study

Jun Luo et al.

ANNALS OF SURGICAL ONCOLOGY (2011)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review

Luis Calzadilla Bertot et al.

EUROPEAN RADIOLOGY (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Survival After Yttrium-90 Resin Microsphere Radioembolization of Hepatocellular Carcinoma Across Barcelona Clinic Liver Cancer Stages: A European Evaluation

Bruno Sangro et al.

HEPATOLOGY (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

A new classification for hepatocellular carcinoma with portal vein tumor thrombus

Jie Shi et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2011)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival

Goh Eun Chung et al.

RADIOLOGY (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes

Riad Salem et al.

GASTROENTEROLOGY (2010)

添加到收藏夹

Article Gastroenterology & Hepatology

Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival

Philip Hilgard et al.

HEPATOLOGY (2010)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Report of the 18th follow-up survey of primary liver cancer in Japan

Iwao Ikai et al.

HEPATOLOGY RESEARCH (2010)

添加到收藏夹

Article Surgery

Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus

Bao-Gang Peng et al.

AMERICAN JOURNAL OF SURGERY (2009)

添加到收藏夹

Article Oncology

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann-Lii Cheng et al.

LANCET ONCOLOGY (2009)

添加到收藏夹

Article Medicine, General & Internal

Sorafenib in advanced hepatocellular carcinoma

Josep M. Llovet et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

添加到收藏夹

Article Surgery

Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy

Li-Jian Liang et al.

WORLD JOURNAL OF SURGERY (2008)

添加到收藏夹

Article Biochemical Research Methods

Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences

Weizhong Li et al.

BIOINFORMATICS (2006)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Percutaneous radiofrequency ablation of hepatic tumors: Postablation syndrome

GD Dodd et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2005)

添加到收藏夹

Article Oncology

Randomized controlled trial of screening for hepatocellular carcinoma

BH Zhang et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)

添加到收藏夹

Article Medicine, General & Internal

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial

JM Llovet et al.

LANCET (2002)

添加到收藏夹

Article Gastroenterology & Hepatology

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

CM Lo et al.

HEPATOLOGY (2002)

添加到收藏夹

Review Gastroenterology & Hepatology

Portal vein thrombosis in adults: pathophysiology, pathogenesis and management

DC Valla et al.

JOURNAL OF HEPATOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.